Collegium Pharmaceutical Reaches Analyst Target Price
March 26, 2024 at 07:05 AM EDT
In recent trading, shares of Collegium Pharmaceutical Inc (COLL) have crossed above the average analyst 12-month target price of $40.00, changing hands for $40.16/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..